nomifensine was withdrawn from markets worldwide because of reports of serious hypersensitivity reactions , especially hemolytic anemia , and marketing of bupropion in the united states was delayed after seizures occurred in bulimic patients in clinical trials .
C0085208
bupropion
C0036572
seizures